Form 4 for BVS Bioventus Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-15 · accession 0001578563-25-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-18 | 2025-02-15 | BVS | D'Adamio Anthony | SVP, GC | M - OptEx | $0.00 | +13.0K | 122.6K | +12% | $0 |
| D | 2025-02-18 | 2025-02-15 | BVS | D'Adamio Anthony | SVP, GC | M - OptEx | $0.00 | -13.0K | 38.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-15 | M | A | 12,980 | $0.00 | 122,558 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-02-15 | M | D | 12,980 | $0.00 | 38,940 | D | — · — to — | 12,980 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date. |